QuantaMatrix Inc
317690
Company Profile
Business description
QuantaMatrix Inc is engaged in research and development, production, and sales of in vitro diagnostic (IVD) medical devices that utilize substances collected from the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment effectiveness, targeting domestic and foreign general hospitals and testing contract institutions.
Contact
131, Gasan digital 1-ro, Geumcheon-gu
16th floor, Bidong (Gasan-dong, BYC High City)
Seoul08506
KORT: +82 269563458
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
94
Stocks News & Analysis
stocks
Chart of the Week: Has gold reached bear market territory?
Investors are facing a shifting landscape.
stocks
Fair value upgrade for this ASX income player
Headwinds in listed energy stocks likely to have passed
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,885.60 | 59.90 | 0.68% |
| CAC 40 | 7,952.10 | 135.16 | 1.73% |
| DAX 40 | 23,233.89 | 553.85 | 2.44% |
| Dow JONES (US) | 46,341.51 | 1,125.37 | 2.49% |
| FTSE 100 | 10,353.31 | 176.86 | 1.74% |
| HKSE | 25,294.03 | 505.89 | 2.04% |
| NASDAQ | 21,590.63 | 795.99 | 3.83% |
| Nikkei 225 | 53,739.68 | 2,675.96 | 5.24% |
| NZX 50 Index | 12,825.87 | 86.24 | -0.67% |
| S&P 500 | 6,528.52 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,671.80 | 53.10 | 0.62% |
| SSE Composite Index | 3,948.55 | 56.69 | 1.46% |